Cargando…
Macrophage Differentiation and Polarization Regulate the Release of the Immune Checkpoint Protein V-Domain Ig Suppressor of T Cell Activation
Recently, the V-domain immunoglobulin suppressor of T-cell activation (VISTA) was identified as a negative immune checkpoint regulator (NCR) that is mainly expressed in hematopoietic cells. Preclinical studies have shown that VISTA blockade results in impeded tumor growth and improved survival. Neve...
Autores principales: | Noubissi Nzeteu, Gaetan Aime, Schlichtner, Stephanie, David, Sulamith, Ruppenstein, Aylin, Fasler-Kan, Elizaveta, Raap, Ulrike, Sumbayev, Vadim V., Gibbs, Bernhard F., Meyer, N. Helge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132587/ https://www.ncbi.nlm.nih.gov/pubmed/35634346 http://dx.doi.org/10.3389/fimmu.2022.837097 |
Ejemplares similares
-
Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-β1 – Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T Lymphocytes
por: Schlichtner, Stephanie, et al.
Publicado: (2022) -
T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins
por: Schlichtner, Stephanie, et al.
Publicado: (2023) -
Editorial: Pathological reactions of cytotoxic lymphoid cells as universal therapeutic targets in cancer and autoimmune disease
por: Sumbayev, Vadim V., et al.
Publicado: (2023) -
Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity
por: Yasinska, Inna M., et al.
Publicado: (2020) -
Nanoparticle-based immunotherapy of pancreatic cancer
por: Noubissi Nzeteu, Gaetan Aime, et al.
Publicado: (2022)